Arcellx (ACLX) Cash & Current Investments (2021 - 2025)

Arcellx's (ACLX) quarterly Cash & Current Investments came in at $450.3 million in Q4 2025, down 23.33% year-on-year from $587.4 million in Q4 2024, and down 2.39% quarter-over-quarter from $461.4 million in Q3 2025.

Arcellx (ACLX) Cash & Current Investments (2021 - 2025) Analysis & Trends

Arcellx's Cash & Current Investments history runs 5 years deep, the most recent figure standing at $450.3 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 23.33% year-over-year to $450.3 million in Q4 2025; TTM through Dec 2025 was $450.3 million, a 23.33% decrease from a year earlier, with the FY2025 full-year figure at $450.3 million, down 23.33% from the prior year.
  • Cash & Current Investments slipped to $450.3 million in Q4 2025 per ACLX's latest filing, from $461.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $702.0 million in Q4 2023 and bottomed at $62.3 million in Q2 2025.
  • The 5-year median for Cash & Current Investments is $245.9 million (2022), against an average of $300.1 million.
  • Across the five-year window, Cash & Current Investments jumped 993.84% in 2023 and plunged 80.21% in 2024, its largest moves.
  • Year by year, Cash & Current Investments stood at $104.6 million in 2021, then sank by 38.65% to $64.2 million in 2022, then soared by 993.84% to $702.0 million in 2023, then declined by 16.33% to $587.4 million in 2024, then retreated by 23.33% to $450.3 million in 2025.
  • Per Business Quant, the three latest ACLX Cash & Current Investments figures stand at $450.3 million (Q4 2025), $461.4 million (Q3 2025), and $62.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - 283.54 Mn
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - 61.40 Mn
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.79 Bn 62.79 Bn - -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 3.01 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 450.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 450.33 Mn
Sep 30, 2025 461.38 Mn
Jun 30, 2025 62.34 Mn
Mar 31, 2025 543.27 Mn
Dec 31, 2024 587.38 Mn
Sep 30, 2024 162.05 Mn
Jun 30, 2024 100.23 Mn
Mar 31, 2024 154.78 Mn
Dec 31, 2023 702.02 Mn
Sep 30, 2023 439.72 Mn
Jun 30, 2023 506.48 Mn
Mar 31, 2023 533.59 Mn
Dec 31, 2022 64.18 Mn
Sep 30, 2022 280.78 Mn
Jun 30, 2022 306.99 Mn
Mar 31, 2022 210.93 Mn
Dec 31, 2021 104.62 Mn
Sep 30, 2021 70.03 Mn
Jun 30, 2021 143.79 Mn
Mar 31, 2021 117.65 Mn